Rasmus Holm-Jorgensen

Insider Reports History

Location
Watertown, MA
Signature
/s/ Rasmus Holm-Jorgensen
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Rasmus Holm-Jorgensen:

Company Role Class Num Shares Value Price $ Report Date Ownership
Acrivon Therapeutics, Inc. Chief Financial Officer Common Stock 26,088 $141,397 $5.42 14 Feb 2025 Direct
Acrivon Therapeutics, Inc. Chief Financial Officer Stock Option (Right to Buy) 109,309 01 Mar 2025 Direct

Insider Reports Filed by Rasmus Holm-Jorgensen

Symbol Company Period Transactions Value $ Form Type Role Filing Time
ACRV Acrivon Therapeutics, Inc. 01 Mar 2025 1 $0 4 Chief Financial Officer 04 Mar 2025, 17:28
ACRV Acrivon Therapeutics, Inc. 14 Feb 2025 1 -$2,352 4 Chief Financial Officer 19 Feb 2025, 16:55
ACRV Acrivon Therapeutics, Inc. 14 Nov 2024 1 -$2,915 4 Chief Financial Officer 18 Nov 2024, 16:30
ACRV Acrivon Therapeutics, Inc. 14 Aug 2024 1 -$2,583 4 Chief Financial Officer 16 Aug 2024, 16:51
ACRV Acrivon Therapeutics, Inc. 14 May 2024 1 -$3,076 4 Chief Financial Officer 16 May 2024, 19:00
ACRV Acrivon Therapeutics, Inc. 01 Mar 2024 1 $0 4 Chief Financial Officer 27 Nov 2024, 18:10
ACRV Acrivon Therapeutics, Inc. 14 Feb 2024 1 -$1,476 4 Chief Financial Officer 16 Feb 2024, 17:12
ACRV Acrivon Therapeutics, Inc. 14 Nov 2023 1 -$7,468 4 Chief Financial Officer 16 Nov 2023, 19:42
ACRV Acrivon Therapeutics, Inc. 16 Jun 2023 2 +$34,485 4 Chief Financial Officer 20 Jun 2023, 17:21
ACRV Acrivon Therapeutics, Inc. 14 Nov 2022 2 $0 4 Chief Financial Officer 16 Nov 2022, 18:13
ACRV Acrivon Therapeutics, Inc. 09 Nov 2022 0 $0 3 Chief Financial Officer 09 Nov 2022, 19:30